Vienna (Austria), December 31, 2005 - In this past year, H.M. Pharma Consultancy, which offers strategic services to the biomedical industry in the fields of R&D, intellectual property, and corporate communications, has increased its turnover by 21 percent over 2004.

"For all but one of the six years since 2000, our annual turnover has grown in the two-digit percentage range," said Hermann Mucke, PhD, founder and principal of H.M. Pharma Consultancy. "Acquisition of new customers, especially in Central and Eastern Europe, has once again boosted our business beyond our own forecasts. We perceive this as a challenge not only to expand, but also to deepen and solidify our scope of activities within the next years."